所有图片(4)

文件

S8875

碳酸氢钠

Name: 碳酸氢钠
Brand: SIGALD

ReagentPlus^®, ≥99.5%, powder

别名:

碳酸氢钠，EMPROVE® ESSENTIAL，符合Ph Eur、BP、JP、USP、FCC、E 500标准, 小苏打

登录查看公司和协议定价

所有图片(4)

About This Item

线性分子式:

NaHCO₃

CAS号:

144-55-8

分子量:

84.01

Beilstein:

4153970

EC號碼:

205-633-8

MDL號碼:

MFCD00003528

分類程式碼代碼:

12352302

PubChem物質ID:

329824613

NACRES:

NA.21

推荐产品

Slide 1 of 10

1 of 10

Sigma-Aldrich

S5761

碳酸氢钠

Sigma-Aldrich

S6014

碳酸氢钠

Sigma-Aldrich

S6297

碳酸氢钠

Sigma-Aldrich

S8761

碳酸氢钠溶液

Supelco

1.06329

碳酸氢钠，EMPROVE® ESSENTIAL，符合Ph Eur、BP、JP、USP、FCC、E 500标准

Sigma-Aldrich

P8412

邻苯二胺二盐酸盐

Sigma-Aldrich

792519

碳酸氢钠

Sigma-Aldrich

W700433

碳酸氢钠

Sigma-Aldrich

S7795

无水碳酸钠

Sigma-Aldrich

P9187

SIGMAFAST^™ OPD

agency

suitable for EPA 300

產品線

ReagentPlus^®

化驗

≥99.5%

形狀

powder

pKa (25 °C)

(1) 6.37, (2) 10.25 (carbonic acid)

密度

2.16 g/mL at 25 °C (lit.)

SMILES 字串

[Na+].OC([O-])=O

InChI

1S/CH2O3.Na/c2-1(3)4;/h(H2,2,3,4);/q;+1/p-1

InChI 密鑰

UIIMBOGNXHQVGW-UHFFFAOYSA-M

正在寻找类似产品? 访问产品对比指南

一般說明

碳酸氢钠通常被称为小苏打。它作为二氧化碳的来源，并用于制备各种钠盐。它也是一种重要的 ph 调节剂。

應用

碳酸氢钠可用作催化剂：

在硫酸钠作助催化剂的情况下，由相应的醛和盐酸羟胺合成腈。
用取代 2-甲酰苯基 2-溴乙酸酯分子内维蒂希反应制备香豆素衍生物。
通过与乙酸酐反应，用于伯醇和酚的乙酰化过程。

法律資訊

ReagentPlus is a registered trademark of Merck KGaA, Darmstadt, Germany

儲存類別代碼

13 - Non Combustible Solids

水污染物質分類（WGK）

WGK 1

閃點（°F）

Not applicable

閃點（°C）

Not applicable

分析证书(COA)

输入产品批号来搜索分析证书(COA) 。批号可以在产品标签上"批“ （Lot或Batch）字后找到。

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

其他客户在看

Slide 1 of 5

1 of 5

Sigma-Aldrich

B3295

生物氨基己酰基-6-氨基己酸N-羟基琥珀酰亚胺酯

Sigma-Aldrich

S9625

氯化钠

Sigma-Aldrich

S8761

碳酸氢钠溶液

Sigma-Aldrich

222321

无水碳酸钠

NIST2191A

碳酸氢钠

Sodium bicarbonate infusion to reduce cardiac surgery-associated acute kidney injury: a phase II multicenter double-blind randomized controlled trial.

Shay P McGuinness et al.

Critical care medicine, 41(7), 1599-1607 (2013-05-21)

Cardiac surgery-associated acute kidney injury occurs in up to 50% of patients and is associated with increased mortality and morbidity. This study aimed to discover if perioperative urinary alkalinization with sodium bicarbonate infusion reduces the prevalence of cardiac surgery-associated acute

Sodium bicarbonate for the prevention of contrast induced-acute kidney injury: a systematic review and meta-analysis.

Somjot S Brar et al.

Clinical journal of the American Society of Nephrology : CJASN, 4(10), 1584-1592 (2009-08-29)

Infusion of sodium bicarbonate has been suggested as a preventative strategy but reports are conflicting on its efficacy. The aim of this study was to assess the effectiveness of hydration with sodium bicarbonate for the prevention of contrast-induced acute kidney

Hypoxia, not pulmonary vascular pressure, induces blood flow through intrapulmonary arteriovenous anastomoses.

Joshua C Tremblay et al.

The Journal of physiology, 593(3), 723-737 (2014-11-25)

Blood flow through intrapulmonary arteriovenous anastomoses (IPAVA) is increased by acute hypoxia during rest by unknown mechanisms. Oral administration of acetazolamide blunts the pulmonary vascular pressure response to acute hypoxia, thus permitting the observation of IPAVA blood flow with minimal

Systematic review: sodium bicarbonate treatment regimens for the prevention of contrast-induced nephropathy.

Sophia Zoungas et al.

Annals of internal medicine, 151(9), 631-638 (2009-11-04)

Intravenous sodium bicarbonate has been proposed to reduce the risk for contrast-induced nephropathy (CIN). To determine the effect of sodium bicarbonate on the risk for CIN. MEDLINE, PubMed, EMBASE, and the Cochrane Central Register of Controlled Trials from 1950 to

Sodium bicarbonate for prevention of contrast-induced acute kidney injury: a systematic review and meta-analysis.

Eric A J Hoste et al.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 25(3), 747-758 (2009-08-26)

There have been conflicting reports on the use of intravenous administration of sodium bicarbonate for prevention of contrast-induced acute kidney injury (CI-AKI). The aim of this study was to evaluate the use of sodium bicarbonate for prevention of CI-AKI. This

查看所有相关文献

实验方案

Enzymatic Assay of Amyloglucosidase (EC 3.2.1.3)

This procedure may be used for the determination of Amyloglucosidase activity using starch as the substrate.

Enzymatic Assay of Amyloglucosidase (EC 3.2.1.3)

This procedure may be used for the determination of Amyloglucosidase activity using starch as the substrate.

Enzymatic Assay of Amyloglucosidase (EC 3.2.1.3)

This procedure may be used for the determination of Amyloglucosidase activity using starch as the substrate.

Enzymatic Assay of Amyloglucosidase (EC 3.2.1.3)

This procedure may be used for the determination of Amyloglucosidase activity using starch as the substrate.

查看所有结果

文件

碳酸氢钠